Highlights and Announcements

Photograph of Dr. Daniel Reich
Friday, April 19, 2024

Dr. Reich is recognized for his achievements in developing new MRI methodologies

NIH Stroke Scale Visual Stimuli
Friday, March 1, 2024
The National Institutes of Health Stroke Scale (NIHSS), or NIH Stroke Scale, is the most widely used tool for health professionals to assess the severity of a stroke. Developed more than 30 years ago, the NIH Stroke Scale has recently been updated with new visual stimuli and is available for download.
NIH logo
Tuesday, February 20, 2024
The National Institutes of Health (NIH) has selected 10 recipients of the NIH Institutional Excellence in Diversity, Equity, Inclusion, and Accessibility (DEIA) in Biomedical and Behavioral Research Prize. Among the awardees—each receiving $100,000—is the University of Puerto Rico-Rio Piedras (UPR-RP) in recognition of their Neuroscience Research Opportunities to Increase Diversity (NeuroID) program.
Diverse team of scientists in the lab.
Monday, December 11, 2023
Team science expands our ability to pursue some of the most challenging problems in neuroscience in a comprehensive, multidisciplinary, and mechanistic manner. The National Institute of Neurological Disorders and Stroke (NINDS) announces the first round of awards for the new NINDS Collaborative Opportunities for Multidisciplinary, Bold, and Innovative Neuroscience (COMBINE) program.
Scientist holding drug.
Tuesday, October 31, 2023
ReveraGen BioPharma, a company supported by a small business grant from the National Institute of Neurological Disorders and Stroke (NINDS), has developed a new drug for Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease.
Motor neuron connecting to muscle cells.
Thursday, October 5, 2023
The National Institutes of Health is committed to advancing research on amyotrophic lateral sclerosis (ALS).
Tuesday, September 26, 2023
In the human brain, 86 billion neurons form more than 100 trillion connections with other neurons at junctions called synapses. Scientists are now working on an ambitious effort to develop technologies to map these connections across the brain, from mice to humans.
Photo of Jeffrey Diamond
Thursday, August 3, 2023
Today, the National Institute of Neurological Disorders and Stroke (NINDS) announced the selection of neuroscientist Jeffrey S. Diamond, Ph.D., as Scientific Director.
Understanding and Managing Migraine in Kids and Teens Guest Dr. Michael Oshinksy Spotlight on Migraine Podcast
Thursday, July 27, 2023
Dr. Michael Oshinsky, Director of the NINDS Office of Preclinical Pain Research, is the featured guest on the July 27 episode of the Spotlight on Migraine podcast, “Understanding and Managing Migraine in Kids and Teens.”
3D illustration of a DNA repair enzyme binding to a double-strand break in DNA
Tuesday, July 11, 2023

Genome editing, which enables precise modifications to DNA, has the potential to lead to breakthrough treatments for diseases caused by genetic changes.